Short Interest in 22nd Century Group, Inc. (NASDAQ:XXII) Expands By 1,933.3%

22nd Century Group, Inc. (NASDAQ:XXII) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 91,500 shares, a growth of 1,933.3% from the December 15th total of 4,500 shares. Approximately 19.5% of the shares of the company are sold short. Based on an average trading volume of 109,400 shares, the days-to-cover ratio is currently 0.8 days.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered 22nd Century Group from a “hold” rating to a “sell” rating in a research note on Tuesday, December 31st.

22nd Century Group Price Performance

Shares of XXII stock traded up $1.11 during mid-day trading on Monday, reaching $6.00. The company’s stock had a trading volume of 23,260,225 shares, compared to its average volume of 3,640,817. The firm’s 50-day moving average is $9.91 and its two-hundred day moving average is $41.98. The company has a market cap of $3.32 million, a P/E ratio of -0.27 and a beta of 1.59. 22nd Century Group has a 1-year low of $3.90 and a 1-year high of $581.85. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.93 and a current ratio of 1.09.

22nd Century Group (NASDAQ:XXII) last posted its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($72.90) earnings per share (EPS) for the quarter. The business had revenue of $5.95 million during the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%.

Institutional Trading of 22nd Century Group

An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP acquired a new stake in shares of 22nd Century Group, Inc. (NASDAQ:XXII) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 18.06% of the company’s stock.

About 22nd Century Group

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.